Abstract:1477 Objectives Noninvasive detection of apoptosis may play an important role in the evaluation of therapy efficiency and disease progression. In this study, we aim to develop Annexin A5-functionalized nanoparticles for dual optical/nuclear imaging of apoptosis. Methods Poly (ethylene glycol) (PEG)-coated, core-crosslinked polymeric micelles (CCPM) were dual-labeled with a near-infrared fluorescence fluorophores (Cy7) and a radioisotope (111In). CCPM nanoparticles were conjugated with Annexin A5. To evaluate the specificity of Annexin A5-CCPM to apoptotic cells, three different preclinical models of apoptosis, including a tumor model, a liver apoptosis model, and an inflammation model were carried out. Results In mice bearing EL4 lymphoma treated with cyclophosphamide and etoposide, the tumor apoptosis was clearly visualized by both SPECT and fluorescence molecular tomography after i.v. administration of 111In-labeled Annexin A5-CCPM. In contrast, there was little accumulation of this nanoradiotracer in the tumors of untreated mice. The biodistribution data was consistent with the imaging data. In liver apoptosis model, the apoptotic liver induced by anti-Fas antibody was clearly visualized by both nuclear and optical images. In contrast, significantly lower signals were detected in healthy livers of untreated mice after injection of 111In-labeled Annexin A5-CCPM and in apoptotic livers after injection of 111In-labeled CCPM. Similarly, 111In-labeled Annexin A5-CCPM showed a significantly higher uptake in the site of inflammation induced by intramuscular injection of turpentine (4.9 %ID/g) than that in the healthy site (0.6 %ID/g). Moreover, in all three models, histological analysis revealed colocalization between radioactivity and fluorescence signals from the nanoparticles, and drug-induced apoptosis. Conclusions Annexin A5-CCPM allowed visualization of apoptosis by both nuclear and optical techniques. The complementary information acquired with multiple imaging techniques should be advantageous in assessing and validating early response to therapy

Preparation and in Vitro Evaluation of Human Recombinant Annexin V Using for Apoptosis

New method for the analysis of cell cycle-specific apoptosis.

The Expression and Purificiation of Human Annexin V Overexpressed in E. Coli and the Detection of Apoptosis

Expression, purification and use of recombinant annexin V for the detection of apoptotic cells

Preparation and Preliminary Evaluation of 125,131I Labeled Human Recombinant Annexin Ⅴ

Preparation, in Vitro and in Vivo Evaluation of (99M)tc-Annexin B1: a Novel Radioligand for Apoptosis Imaging.

Screening, purification, and identification of annexin B1 mutants with high phosphatidylserine-binding activity and reduced immunogenicity

Construction of Biotinylated Annexin V for Detection of Apoptosis

Development Progress of Apoptosis Imaging with Radioactive Annexin V

Preparation and bioevaluation of 88Tcm-HYNIC-Annexin B1 as a novel radiotracer for apoptosis detection

Secretion of Recombinant Human Annexin V in Fusion with the Super Folder GFP for Labelling Phosphatidylserine-Exposing Membranes

Preparation and bioevaluation of 99mTc-Annexin B1 as a novel radiotracer for apoptosis imaging

Production of Biologically Active Recombinant Annexin B1 with Enhanced Stability Via a Tagging System

Expression, Purification and Activity Detection in Vitro of Apoptin

Recombination Expression and Cytolytic Bioactivity of vvhA Fusion Protein:Cytolysin of V.vulnificus

Preparation and Identification of Monoclonal Antibody Against Annexini

Preparation of 99Tcm-Annexin V and in vitro study of its binding characteristics in dopaminergic apoptotic neurons

Preparation and bioevaluation of 99m Tc-HYNIC-annexin B1 as a novel radioligand for apoptosis imaging

Study on VVC recombinant protein cytolytic activity mechanism of an extracellular cytolytic toxin of Vibrio vulnificus

Annexin A5-functionalized nanoparticles for in vivo dual modality imaging of apoptosis

Experimental Studies on Apoptosis Imaging of 153Sm-Annexin V